Randy D. Blakely

Q: What Schools Are Affiliated With Randy D. Blakely

Randy D. Blakely is affiliated with the following schools: Emory University, University of Toronto, Yale University, Augusta University, Vanderbilt University, Oregon Health & Science University, University of Pittsburgh, University of Georgia, Florida Atlantic University

Randy D. Blakely's AcademicInfluence.com Rankings

Randy D. Blakely

Medical

#1856

World Rank

#2235

Historical Rank

Pharmacology

#178

World Rank

#217

Historical Rank

medical Degrees

Download Badge

Medical

Randy D. Blakely's Degrees

PhD Pharmacology Vanderbilt University
Bachelors Biology University of Georgia

Similar Degrees You Can Earn

Best Online Bachelor's in Biology 2025

Why Is Randy D. Blakely Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Randy D. Blakely's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Expression cloning of a cocaine-and antidepressant-sensitive human noradrenaline transporter (1991) (899)
Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. (1993) (871)
Pharmacological profile of antidepressants and related compounds at human monoamine transporters. (1997) (855)
Cloning and expression of a functional serotonin transporter from rat brain (1991) (789)
Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency. (2000) (569)
The Proinflammatory Cytokines Interleukin-1beta and Tumor Necrosis Factor-Alpha Activate Serotonin Transporters (2006) (492)
A transient placental source of serotonin for the fetal forebrain (2011) (465)
Molecular physiology of norepinephrine and serotonin transporters. (1994) (389)
Protein Kinase C Activation Regulates Human Serotonin Transporters in HEK-293 Cells via Altered Cell Surface Expression (1997) (386)
Dopaminergic neuronal loss and motor deficits in Caenorhabditis elegans overexpressing human α‐synuclein (2003) (385)
Neurotoxin-induced degeneration of dopamine neurons in Caenorhabditis elegans (2002) (372)
Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants. (1999) (371)
Allelic heterogeneity at the serotonin transporter locus (SLC6A4) confers susceptibility to autism and rigid-compulsive behaviors. (2005) (370)
Targeting cell surface receptors with ligand-conjugated nanocrystals. (2002) (322)
Phosphorylation and Regulation of Antidepressant-sensitive Serotonin Transporters* (1998) (301)
Hydrolysis of the brain dipeptide N-acetyl-L-aspartyl-L-glutamate. Identification and characterization of a novel N-acetylated alpha-linked acidic dipeptidase activity from rat brain. (1987) (299)
Amphetamine induces dopamine efflux through a dopamine transporter channel. (2005) (284)
Immunolocalization of the cocaine‐ and antidepressant‐sensitive l‐norepinephrine transporter (2000) (281)
Autism gene variant causes hyperserotonemia, serotonin receptor hypersensitivity, social impairment and repetitive behavior (2012) (273)
A dialogue between the immune system and brain, spoken in the language of serotonin. (2013) (254)
Surface modification to reduce nonspecific binding of quantum dots in live cell assays. (2005) (252)
Biogenic amine transporters: regulation in flux (2000) (251)
Interleukin-1 Receptor Activation by Systemic Lipopolysaccharide Induces Behavioral Despair Linked to MAPK Regulation of CNS Serotonin Transporters (2010) (249)
Cocaine and Antidepressant-Sensitive Biogenic Amine Transporters Exist in Regulated Complexes with Protein Phosphatase 2A (2000) (240)
Clustering autism: using neuroanatomical differences in 26 mouse models to gain insight into the heterogeneity (2014) (233)
Vesicular Localization and Activity-Dependent Trafficking of Presynaptic Choline Transporters (2003) (215)
p38 MAPK Activation Elevates Serotonin Transport Activity via a Trafficking-independent, Protein Phosphatase 2A-dependent Process* (2005) (214)
Molecular cloning and expression of a high affinity l-proline transporter expressed in putative glutamatergic pathways of rat brain (1992) (212)
The effect of N-linked glycosylation on activity of the Na(+)- and Cl(-)-dependent serotonin transporter expressed using recombinant baculovirus in insect cells. (1994) (209)
Functional characterization and chromosomal localization of a cloned taurine transporter from human placenta. (1994) (205)
Acetylcholine is an autocrine or paracrine hormone synthesized and secreted by airway bronchial epithelial cells. (2004) (200)
Transmembrane Domain I Contributes to the Permeation Pathway for Serotonin and Ions in the Serotonin Transporter (1999) (192)
Regulated phosphorylation and trafficking of antidepressant-sensitive serotonin transporter proteins (1998) (187)
Monoamine Oxidase A–Mediated Enhanced Catabolism of Norepinephrine Contributes to Adverse Remodeling and Pump Failure in Hearts With Pressure Overload (2010) (184)
Molecular cloning of a human, hemicholinium-3-sensitive choline transporter. (2000) (179)
Cloning, expression, and localization of a chloride-facilitated, cocaine-sensitive serotonin transporter from Drosophila melanogaster. (1994) (176)
Norepinephrine transporters have channel modes of conduction. (1996) (171)
Inability to N-glycosylate the human norepinephrine transporter reduces protein stability, surface trafficking, and transport activity but not ligand recognition. (1996) (168)
Tyr-95 and Ile-172 in Transmembrane Segments 1 and 3 of Human Serotonin Transporters Interact to Establish High Affinity Recognition of Antidepressants* (2006) (167)
Human serotonin transporter variants display altered sensitivity to protein kinase G and p38 mitogen-activated protein kinase. (2005) (166)
High Affinity Recognition of Serotonin Transporter Antagonists Defined by Species-scanning Mutagenesis (1998) (166)
Acute regulation of norepinephrine transport: II. PKC-modulated surface expression of human norepinephrine transporter proteins. (1998) (166)
Interactions between integrin alphaIIbbeta3 and the serotonin transporter regulate serotonin transport and platelet aggregation in mice and humans. (2008) (165)
The Caenorhabditis elegans gene T23G5.5 encodes an antidepressant- and cocaine-sensitive dopamine transporter. (1998) (165)
Adenosine receptor, protein kinase G, and p38 mitogen-activated protein kinase-dependent up-regulation of serotonin transporters involves both transporter trafficking and activation. (2004) (163)
Sodium-dependent norepinephrine-induced currents in norepinephrine-transporter-transfected HEK-293 cells blocked by cocaine and antidepressants. (1995) (159)
A Regulated Interaction of Syntaxin 1A with the Antidepressant-Sensitive Norepinephrine Transporter Establishes Catecholamine Clearance Capacity (2003) (156)
Acute regulation of norepinephrine transport: I. protein kinase C-linked muscarinic receptors influence transport capacity and transporter density in SK-N-SH cells. (1998) (156)
Dopamine transporters depolarize neurons by a channel mechanism. (2004) (151)
Vaccinia-T7 RNA polymerase expression system: evaluation for the expression cloning of plasma membrane transporters. (1991) (149)
Cloning and expression of the mouse serotonin transporter. (1996) (148)
A polymorphism in the norepinephrine transporter gene alters promoter activity and is associated with attention-deficit hyperactivity disorder (2006) (147)
Carrier-mediated uptake of the endogenous cannabinoid anandamide in RBL-2H3 cells. (2000) (146)
Lethal impairment of cholinergic neurotransmission in hemicholinium-3-sensitive choline transporter knockout mice. (2004) (145)
Hypoinsulinemia Regulates Amphetamine-Induced Reverse Transport of Dopamine (2007) (142)
The choline transporter resurfaces: new roles for synaptic vesicles? (2004) (142)
Monoamine transporter gene structure and polymorphisms in relation to psychiatric and other complex disorders (2002) (135)
Chimeric human and rat serotonin transporters reveal domains involved in recognition of transporter ligands. (1994) (131)
Serotonin Transporter Function Is an Early Step in Left-Right Patterning in Chick and Frog Embryos (2005) (125)
Human norepinephrine transporter. Biosynthetic studies using a site-directed polyclonal antibody. (1994) (122)
Anomalous Dopamine Release Associated with a Human Dopamine Transporter Coding Variant (2008) (121)
Going with the Flow: Trafficking‐Dependent and ‐Independent Regulation of Serotonin Transport (2008) (120)
Evidence for Biphasic Effects of Protein Kinase C on Serotonin Transporter Function, Endocytosis, and Phosphorylation (2005) (120)
Vigorous Motor Activity in Caenorhabditis elegans Requires Efficient Clearance of Dopamine Mediated by Synaptic Localization of the Dopamine Transporter DAT-1 (2007) (119)
Cell-specific Sorting of Biogenic Amine Transporters Expressed in Epithelial Cells* (1996) (119)
The functional impact of SLC6 transporter genetic variation. (2007) (118)
A Mutation in the Human Norepinephrine Transporter Gene (SLC6A2) Associated with Orthostatic Intolerance Disrupts Surface Expression of Mutant and Wild-Type Transporters (2003) (117)
Norepinephrine Modulates Glutamatergic Transmission in the Bed Nucleus of the Stria Terminalis (2005) (117)
Transient developmental expression of monoamine transporters in the rodent forebrain. (1998) (116)
Vesicular and plasma membrane transporters for neurotransmitters. (2012) (116)
Enhanced activity of human serotonin transporter variants associated with autism (2009) (114)
Regulation of the human serotonin transporter. Cholera toxin-induced stimulation of serotonin uptake in human placental choriocarcinoma cells is accompanied by increased serotonin transporter mRNA levels and serotonin transporter-specific ligand binding. (1993) (114)
The Caenorhabditis elegans dopaminergic system: opportunities for insights into dopamine transport and neurodegeneration. (2003) (114)
Networking in Autism: Leveraging Genetic, Biomarker and Model System Findings in the Search for New Treatments (2012) (113)
Trafficking-dependent and -independent pathways of neurotransmitter transporter regulation differentially involving p38 mitogen-activated protein kinase revealed in studies of insulin modulation of norepinephrine transport in SK-N-SH cells. (2001) (111)
Expression of a cocaine-sensitive norepinephrine transporter in the human placental syncytiotrophoblast. (1992) (110)
Novel fluorescence-based approaches for the study of biogenic amine transporter localization, activity, and regulation (2005) (110)
Alternative Splicing of the Human Serotonin Transporter Gene (1997) (109)
Localization of cholinergic innervation in guinea pig heart by immunohistochemistry for high-affinity choline transporters. (2004) (107)
The SLC6 transporters: perspectives on structure, functions, regulation, and models for transporter dysfunction (2013) (106)
Dysregulation of Dopamine Transporters via Dopamine D2 Autoreceptors Triggers Anomalous Dopamine Efflux Associated with Attention-Deficit Hyperactivity Disorder (2010) (106)
Co‐localization of N‐acetyl‐aspartyl‐glutamate in central cholinergic, noradrenergic, and serotonergic neurons (1987) (105)
Ultrastructural localization of the serotonin transporter in superficial and deep layers of the rat prelimbic prefrontal cortex and its spatial relationship to dopamine terminals (2000) (104)
Patch-clamp and amperometric recordings from norepinephrine transporters: channel activity and voltage-dependent uptake. (1998) (102)
Serotonin-, Protein Kinase C-, and Hic-5-associated Redistribution of the Platelet Serotonin Transporter* (2006) (102)
Attention Deficit/Hyperactivity Disorder-Derived Coding Variation in the Dopamine Transporter Disrupts Microdomain Targeting and Trafficking Regulation (2012) (102)
Transient developmental expression of monoamine transporters in the rodent forebrain (1998) (100)
Chronic Stress Increases the Plasmalemmal Distribution of the Norepinephrine Transporter and the Coexpression of Tyrosine Hydroxylase in Norepinephrine Axons in the Prefrontal Cortex (2006) (100)
Polarized Expression of the Antidepressant-Sensitive Serotonin Transporter in Epinephrine-Synthesizing Chromaffin Cells of the Rat Adrenal Gland (1997) (99)
Regulation of autism-relevant behaviors by cerebellar–prefrontal cortical circuits (2020) (98)
Psychiatric profile and attention deficits in postural tachycardia syndrome (2008) (97)
Sequence variation in the human dopamine transporter gene in children with attention deficit hyperactivity disorder (2005) (96)
Cell‐Type‐Specific Interleukin 1 Receptor 1 Signaling in the Brain Regulates Distinct Neuroimmune Activities (2019) (96)
SLC6A3 coding variant Ala559Val found in two autism probands alters dopamine transporter function and trafficking (2014) (95)
Serotonin and Cocaine-sensitive Inactivation of Human Serotonin Transporters by Methanethiosulfonates Targeted to Transmembrane Domain I* (2003) (94)
Developing novel treatments for mood disorders: accelerating discovery (2002) (92)
Drosophila Serotonin Transporters Have Voltage-Dependent Uptake Coupled to a Serotonin-Gated Ion Channel (1997) (92)
Hydrolysis of the Brain Dipeptide N‐Acetyl‐l‐Aspartyl‐l‐Glutamate: Subcellular and Regional Distribution, Ontogeny, and the Effect of Lesions on N‐Acetylated‐α‐Linked Acidic Dipeptidase Activity (1988) (91)
Pharmacological profile of neuroleptics at human monoamine transporters. (1999) (91)
Identification of a single amino acid, phenylalanine 586, that is responsible for high affinity interactions of tricyclic antidepressants with the human serotonin transporter. (1996) (90)
5-Hydroxytryptamine drives apoptosis in biopsylike Burkitt lymphoma cells: reversal by selective serotonin reuptake inhibitors. (2002) (90)
Serotonergic dorsal raphe nucleus projections to the cholinergic and noncholinergic neurons of the pedunculopontine tegmental region: a light and electron microscopic anterograde tracing and immunohistochemical study (1997) (89)
Dopamine transporter/syntaxin 1A interactions regulate transporter channel activity and dopaminergic synaptic transmission (2008) (88)
Molecular cloning and characterization of a murine hemicholinium-3-sensitive choline transporter. (2001) (86)
Ultrastructural localization of the norepinephrine transporter in superficial and deep layers of the rat prelimbic prefrontal cortex and its spatial relationship to probable dopamine terminals (2000) (85)
Down‐Regulation of the Human Norepinephrine Transporter in Intact 293‐hNET Cells Exposed to Desipramine (1998) (85)
Cloning and Chromosomal Mapping of the Murine Norepinephrine Transporter (1998) (84)
Biogenic amine neurotransmitter transporters: just when you thought you knew them. (2005) (84)
Single Nucleotide Polymorphisms in the Human Norepinephrine Transporter Gene Affect Expression, Trafficking, Antidepressant Interaction, and Protein Kinase C Regulation (2005) (83)
Pore models for transporters? (1996) (83)
Serotonin transporter variant drives preventable gastrointestinal abnormalities in development and function. (2016) (82)
Expression of Serotonin Transporter Messenger RNA in the Human Brain (1994) (81)
Serotonin increases DNA synthesis in rat proximal and distal pulmonary vascular smooth muscle cells in culture. (1994) (81)
Interactions of tryptamine derivatives with serotonin transporter species variants implicate transmembrane domain I in substrate recognition. (2001) (80)
Defective presynaptic choline transport underlies hereditary motor neuropathy. (2012) (80)
A genetic screen in Caenorhabditis elegans for dopamine neuron insensitivity to 6‐hydroxydopamine identifies dopamine transporter mutants impacting transporter biosynthesis and trafficking (2005) (80)
The neurobiology of N-acetylaspartylglutamate. (1988) (80)
C. elegans: a novel pharmacogenetic model to study Parkinson's disease. (2001) (80)
Sodium‐dependent GABA‐induced currents in GAT1‐transfected HeLa cells. (1996) (80)
Ultrastructural interactions between terminals expressing the norepinephrine transporter and dopamine neurons in the rat and monkey ventral tegmental area (2004) (80)
Binding and Transport in Norepinephrine Transporters (2003) (80)
The serotonin transporter (SLC6A4) is present in B‐cell clones of diverse malignant origin: probing a potential antitumor target for psychotropics (2005) (79)
Functional coding variation in recombinant inbred mouse lines reveals multiple serotonin transporter-associated phenotypes (2009) (78)
Distribution of high affinity choline transporter immunoreactivity in the primate central nervous system (2003) (74)
Single Molecule Analysis of Serotonin Transporter Regulation Using Antagonist-Conjugated Quantum Dots Reveals Restricted, p38 MAPK-Dependent Mobilization Underlying Uptake Activation (2012) (73)
Neurochemical and Immunocytochemical Studies on the Distribution of N‐Acetyl‐Aspartylglutamate and N‐Acetyl‐Aspartate in Rat Spinal Cord and Some Peripheral Nervous Tissues (1987) (73)
Expression of the rat brain creatine transporter in situ and in transfected HeLa cells. (1996) (73)
Human norepinephrine transporter kinetics using rotating disk electrode voltammetry. (1996) (72)
Physiological Genomics of Antidepressant Targets: Keeping the Periphery in Mind (2001) (68)
Kinase-dependent Regulation of Monoamine Neurotransmitter Transporters (2016) (66)
Altered striatal function and muscarinic cholinergic receptors in acetylcholinesterase knockout mice. (2003) (64)
Dopamine Signaling Architecture in Caenorhabditis elegans (2006) (62)
Choline transporter gene variation is associated with attention-deficit hyperactivity disorder (2009) (61)
Immune System Activation and Depression: Roles of Serotonin in the Central Nervous System and Periphery. (2017) (61)
Disposed to Distraction: Genetic Variation in the Cholinergic System Influences Distractibility But Not Time-on-Task Effects (2014) (61)
Regulation of Choline Transporter Surface Expression and Phosphorylation by Protein Kinase C and Protein Phosphatase 1/2A (2004) (59)
Selective immunocytochemical staining of mitral cells in rat olfactory bulb with affinity purified antibodies against N-acetyl-aspartyl-glutamate (1987) (59)
Familial Orthostatic Tachycardia Due to Norepinephrine Transporter Deficiency (2001) (57)
Structural determinants of species‐selective substrate recognition in human and Drosophila serotonin transporters revealed through computational docking studies (2009) (57)
Cholinergic neurons of mouse intrinsic cardiac ganglia contain noradrenergic enzymes, norepinephrine transporters, and the neurotrophin receptors tropomyosin-related kinase A and p75 (2008) (55)
Rapid Stimulation of Presynaptic Serotonin Transport by A3 Adenosine Receptors (2007) (55)
Good riddance to dopamine: Roles for the dopamine transporter in synaptic function and dopamine-associated brain disorders (2014) (55)
The rare DAT coding variant Val559 perturbs DA neuron function, changes behavior, and alters in vivo responses to psychostimulants (2014) (54)
Regulation of Antidepressant-Sensitive Serotonin Transporters (1997) (53)
Amphetamine Induces a Calcium/Calmodulin-Dependent Protein Kinase II-Dependent Reduction in Norepinephrine Transporter Surface Expression Linked to Changes in Syntaxin 1A/Transporter Complexes (2007) (53)
Transgenic elimination of high-affinity antidepressant and cocaine sensitivity in the presynaptic serotonin transporter (2011) (53)
The Presynaptic Choline Transporter Imposes Limits on Sustained Cortical Acetylcholine Release and Attention (2013) (51)
Expression studies of naturally occurring human dopamine transporter variants identifies a novel state of transporter inactivation associated with Val382Ala (2005) (51)
Phosphorylation of Dopamine Transporter Serine 7 Modulates Cocaine Analog Binding* (2012) (51)
Determinants within the C-terminus of the human norepinephrine transporter dictate transporter trafficking, stability, and activity. (2002) (51)
The high-affinity choline transporter: a critical protein for sustaining cholinergic signaling as revealed in studies of genetically altered mice. (2006) (50)
Metabolism of Catecholamines by Catechol‐O‐Methyltransferase in Cells Expressing Recombinant Catecholamine Transporters (1997) (50)
Na+, Cl−, and pH Dependence of the Human Choline Transporter (hCHT) in Xenopus Oocytes: The Proton Inactivation Hypothesis of hCHT in Synaptic Vesicles (2006) (50)
Disruption of Transient Serotonin Accumulation by Non-Serotonin-Producing Neurons Impairs Cortical Map Development (2015) (50)
Modified structure of the human serotonin transporter promoter (2000) (50)
ADHD and the dopamine transporter: are there reasons to pay attention? (2006) (49)
The Caenorhabditis elegans Choline Transporter CHO-1 Sustains Acetylcholine Synthesis and Motor Function in an Activity-Dependent Manner (2006) (49)
Restriction site-independent formation of chimeras from homologous neurotransmitter-transporter cDNAs. (1994) (48)
cGMP-dependent protein kinase Iα associates with the antidepressant-sensitive serotonin transporter and dictates rapid modulation of serotonin uptake (2009) (47)
3D visualization of the regional differences (2015) (45)
Cell surface trafficking of the antidepressant-sensitive norepinephrine transporter revealed with an ectodomain antibody (2003) (45)
Getting the Message Across: A Recent Transporter Structure Shows the Way (2006) (44)
Expression of neurotransmitter transport from rat brain mRNA in Xenopus laevis oocytes. (1988) (43)
Stimulation of serotonin transport by the cyclic GMP phosphodiesterase-5 inhibitor sildenafil. (2004) (43)
Deficits in acetylcholine homeostasis, receptors and behaviors in choline transporter heterozygous mice (2007) (43)
Genetic linkage study of bipolar disorder and the serotonin transporter. (1996) (42)
Subcellular localization of the antidepressant-sensitive norepinephrine transporter (2009) (42)
Visualization of the cocaine-sensitive dopamine transporter with ligand-conjugated quantum dots. (2011) (42)
Modeling rare gene variation to gain insight into the oldest biomarker in autism: construction of the serotonin transporter Gly56Ala knock-in mouse (2009) (41)
Cholinergic capacity mediates prefrontal engagement during challenges to attention: evidence from imaging genetics (2015) (40)
Synaptosomal Transport of Radiolabel from N‐Acetyl‐Aspartyl‐[3H]Glutamate Suggests a Mechanism of Inactivation of an Excitatory Neuropeptide (1986) (40)
Calcium-Dependent Inhibition of Synaptosomal Serotonin Transport by the α2-Adrenoceptor Agonist 5-Bromo-N-[4,5-dihydro-1H-imidazol-2-yl]-6-quinoxalinamine (UK14304) (2003) (39)
Single-quantum-dot tracking reveals altered membrane dynamics of an attention-deficit/hyperactivity-disorder-derived dopamine transporter coding variant. (2015) (39)
Cholinergic genetics of visual attention: Human and mouse choline transporter capacity variants influence distractibility (2016) (39)
Genetic background modulates phenotypes of serotonin transporter Ala56 knock-in mice (2013) (39)
Quisqualate selectively inhibits a brain peptidase which cleaves N-acetyl-L-aspartyl-L-glutamate in vitro. (1986) (39)
Impact of Maternal Serotonin Transporter Genotype on Placental Serotonin, Fetal Forebrain Serotonin, and Neurodevelopment (2017) (39)
Pancreatic deletion of the interleukin-1 receptor disrupts whole body glucose homeostasis and promotes islet β-cell de-differentiation (2018) (39)
Functional Gene Variation in the Human Norepinephrine Transporter (2008) (39)
Quantitation of N-acetyl-aspartyl-glutamate in microdissected rat brain nuclei and peripheral tissues: findings with a novel liquid phase radioimmunoassay. (1988) (38)
A Conserved Asparagine Residue in Transmembrane Segment 1 (TM1) of Serotonin Transporter Dictates Chloride-coupled Neurotransmitter Transport* (2011) (37)
Interrogating the Spatiotemporal Landscape of Neuromodulatory GPCR Signaling by Real-Time Imaging of cAMP in Intact Neurons and Circuits. (2018) (37)
Hereditary Spastic Paraplegia-Associated Mutations in the NIPA1 Gene and Its Caenorhabditis elegans Homolog Trigger Neural Degeneration In Vitro and In Vivo through a Gain-of-Function Mechanism (2008) (37)
Subcellular Localization of Chromogranins, Calcium ChanneAmine Carriers, and Proteins of the Exocytotic Machinery in Bovine Splenic Nerve (1999) (37)
Dependence of Serotonergic and Other Nonadrenergic Enteric Neurons on Norepinephrine Transporter Expression (2010) (36)
Proteomic analysis of human norepinephrine transporter complexes reveals associations with protein phosphatase 2A anchoring subunit and 14-3-3 proteins. (2005) (35)
Calcium-dependent interactions of the human norepinephrine transporter with syntaxin 1A (2007) (35)
An autism-associated serotonin transporter variant disrupts multisensory processing (2017) (35)
A novel nonopioid action of enkephalins: competitive inhibition of the mammalian brain high affinity L-proline transporter. (1996) (34)
Interpretations of Voltammetry in the Striatum Based on Chromatography of Striatal Dialysate (1983) (34)
Biosynthesis, N-glycosylation, and surface trafficking of biogenic amine transporter proteins. (1998) (34)
Neuroleptics increase striatal catecholamine metabolites but not ascorbic acid in dialyzed perfusate (1984) (33)
Molecular Cloning and Characterization of anl-Epinephrine Transporter from Sympathetic Ganglia of the Bullfrog, Rana catesbiana (1997) (33)
Overview: A Rare Opportunity or Just One Less Reason to Be Depressed (2005) (33)
Forward Genetic Analysis to Identify Determinants of Dopamine Signaling in Caenorhabditis elegans Using Swimming-Induced Paralysis (2012) (32)
Norepinephrine transporter-deficient mice respond to anxiety producing and fearful environments with bradycardia and hypotension (2006) (32)
Ultrastructural localization of the norepinephrine transporter in superficial and deep layers of the rat prelimbic prefrontal cortex and its spatial relationship to probable dopamine terminals. (2003) (31)
Colocalization and Regulated Physical Association of Presynaptic Serotonin Transporters with A3 Adenosine Receptors (2011) (31)
Unresponsive Choline Transporter as a Trait Neuromarker and a Causal Mediator of Bottom-Up Attentional Biases (2017) (30)
Distinct, Developmentally Regulated Brain mRNAs Direct the Synthesis of Neurotransmitter Transporters (1991) (30)
Transmembrane Domain 6 of the Human Serotonin Transporter Contributes to an Aqueously Accessible Binding Pocket for Serotonin and the Psychostimulant 3,4-Methylene Dioxymethamphetamine* (2010) (30)
Glial Expression of the Caenorhabditis elegans Gene swip-10 Supports Glutamate Dependent Control of Extrasynaptic Dopamine Signaling (2015) (29)
The SSRI Citalopram Affects Fetal Thalamic Axon Responsiveness to Netrin-1 In vitro Independently of SERT Antagonism (2012) (29)
Tachycardia, reduced vagal capacity, and age-dependent ventricular dysfunction arising from diminished expression of the presynaptic choline transporter. (2010) (29)
Gαo is a major determinant of cAMP signaling in the pathophysiology of movement disorders (2021) (29)
Serotonin and Serotonin Transporters in the Adrenal Medulla: A Potential Hub for Modulation of the Sympathetic Stress Response. (2017) (29)
Rab11 Supports Amphetamine-Stimulated Norepinephrine Transporter Trafficking (2010) (28)
p38α MAPK signaling drives pharmacologically reversible brain and gastrointestinal phenotypes in the SERT Ala56 mouse (2018) (28)
A fluorescence displacement assay for antidepressant drug discovery based on ligand-conjugated quantum dots. (2011) (28)
Quantum dot ex vivo labeling of neuromuscular synapses. (2008) (28)
Autocrine Regulation of Norepinephrine Transporter Expression (2001) (27)
Essential Contributions of Serotonin Transporter Inhibition to the Acute and Chronic Actions of Fluoxetine and Citalopram in the SERT Met172 Mouse (2016) (27)
High affinity inhibitors of the dopamine transporter (DAT): novel biotinylated ligands for conjugation to quantum dots. (2006) (26)
Binding and Transport in Norepinephrine Transporters REAL-TIME, SPATIALLY RESOLVED ANALYSIS IN SINGLE CELLS USING A FLUORESCENT SUBSTRATE* (2003) (26)
Drug Targets in the Embryo (1996) (26)
Generation and Characterization of Mice Expressing a Conditional Allele of the Interleukin-1 Receptor Type 1 (2016) (26)
Dopamine's Reversal of Fortune (2001) (25)
Bound to be different: neurotransmitter transporters meet their bacterial cousins. (2007) (25)
Cocaine modulates mammalian circadian clock timing by decreasing serotonin transport in the SCN (2014) (25)
Inhibitors of the serotonin transporter protein (SERT): the design and synthesis of biotinylated derivatives of 3-(1,2,3,6-tetrahydro-pyridin-4-yl)-1H-indoles. High-affinity serotonergic ligands for conjugation with quantum dots. (2005) (25)
Structural determinants of neurotransmitter transport using cross-species chimeras: studies on serotonin transporter. (1998) (24)
Voltammetric recording from neostriatum of behaving rhesus monkey (1981) (24)
Genetic variation in the presynaptic norepinephrine transporter is associated with blood pressure responses to exercise in healthy humans (2011) (24)
Genetic targeting of the amphetamine and methylphenidate-sensitive dopamine transporter: On the path to an animal model of attention-deficit hyperactivity disorder (2014) (23)
Tails of serotonin and norepinephrine transporters: deletions and chimeras retain function. (1993) (23)
Single Quantum Dot Imaging Reveals PKCβ-Dependent Alterations in Membrane Diffusion and Clustering of an Attention-Deficit Hyperactivity Disorder/Autism/Bipolar Disorder-Associated Dopamine Transporter Variant. (2018) (23)
Region-Specific Regulation of Presynaptic Dopamine Homeostasis by D2 Autoreceptors Shapes the In Vivo Impact of the Neuropsychiatric Disease-Associated DAT Variant Val559 (2018) (23)
Peptide-conjugated quantum dots: imaging the angiotensin type 1 receptor in living cells. (2005) (23)
The design and synthesis of novel derivatives of the dopamine uptake inhibitors GBR 12909 and GBR 12935. High-affinity dopaminergic ligands for conjugation with highly fluorescent cadmium selenide/zinc sulfide core/shell nanocrystals (2003) (23)
Genetic Basis of Clinical Catecholamine Disorders (2002) (22)
Blockade of the 5‐HT transporter contributes to the behavioural, neuronal and molecular effects of cocaine (2017) (22)
Choline transporter mutations in severe congenital myasthenic syndrome disrupt transporter localization (2017) (22)
Functional coding variation in the presynaptic dopamine transporter associated with neuropsychiatric disorders drives enhanced motivation and context-dependent impulsivity in mice (2018) (22)
Labeling of neuronal receptors and transporters with quantum dots. (2012) (21)
Cognitive effects of dopamine depletion in the context of diminished acetylcholine signaling capacity in mice (2012) (21)
Labeling cell-surface proteins via antibody quantum dot streptavidin conjugates. (2005) (20)
Rare coding variants of the adenosine A3 receptor are increased in autism: on the trail of the serotonin transporter regulome (2013) (20)
SNARE-ing neurotransmitter transporters (2000) (19)
Depression in patients with head and neck cancer and a functional genetic polymorphism of the serotonin transporter gene (2012) (19)
Erratum: Cell-Type-Specific Interleukin 1 Receptor 1 Signaling in the Brain Regulates Distinct Neuroimmune Activities (Immunity (2019) 50(2) (317–333.e6), (S1074761318305600) (10.1016/j.immuni.2018.12.012)) (2019) (19)
Monoamine oxidase a promoter gene associated with problem behavior in adults with intellectual/developmental disabilities. (2009) (19)
Length of axons expressing the serotonin transporter in orbitofrontal cortex is lower with age in depression (2017) (18)
Monitoring cholinergic activity during attentional performance in mice heterozygous for the choline transporter: A model of cholinergic capacity limits (2013) (18)
Nonoisotopic assay for the presynaptic choline transporter reveals capacity for allosteric modulation of choline uptake. (2012) (18)
Biotin tethered homotryptamine derivatives: high affinity probes of the human serotonin transporter (hSERT). (2011) (18)
Expression and development of a functional plasmalemmal 5-hydroxytryptamine transporter by thyroid follicular cells. (1996) (18)
A requirement of serotonergic p38α mitogen-activated protein kinase for peripheral immune system activation of CNS serotonin uptake and serotonin-linked behaviors (2015) (17)
Genetic indeterminism, the 5-HTTLPR, and the paths forward in neuropsychiatric genetics. (2011) (17)
Motor neuron-specific overexpression of the presynaptic choline transporter: impact on motor endurance and evoked muscle activity (2010) (17)
Acidic peptides in brain: do they act at putative glutamatergic synapses? (1986) (17)
A re-examination of the interaction of N-acetyl-L-aspartyl-L-glutamate with a subpopulation of rat brain membrane L-[3H]glutamate binding sites. (1988) (17)
The Atypical MAP Kinase SWIP-13/ERK8 Regulates Dopamine Transporters through a Rho-Dependent Mechanism (2017) (16)
Neurobehavioral changes arising from early life dopamine signaling perturbations (2020) (16)
The N-terminus of the norepinephrine transporter regulates the magnitude and selectivity of the transporter-associated leak current (2006) (16)
Dopamine denervation of the prefrontal cortex increases expression of the astrocytic glutamate transporter GLT‐1 (2014) (15)
Blockade and reversal of swimming-induced paralysis in C. elegans by the antipsychotic and D2-type dopamine receptor antagonist azaperone (2019) (15)
Truncating SLC5A7 mutations underlie a spectrum of dominant hereditary motor neuropathies (2018) (15)
Ultrastructural localization of high‐affinity choline transporter in the rat anteroventral thalamus and ventral tegmental area: Differences in axon morphology and transporter distribution (2010) (15)
Identification and Characterization of ML352: A Novel, Noncompetitive Inhibitor of the Presynaptic Choline Transporter (2015) (15)
Synthesis and characterization of a pegylated derivative of 3-(1,2,3,6-tetrahydro-pyridin-4yl)-1H-indole (IDT199): a high affinity SERT ligand for conjugation to quantum dots. (2007) (14)
Interrogating the Spatiotemporal Landscape of Neuromodulatory GPCR Signaling by Real-Time Imaging of cAMP in Intact Neurons and Circuits (2018) (14)
All Aglow about Presynaptic Receptor Regulation of Neurotransmitter Transporters (2007) (14)
Analysis of neuroanatomical differences in mice with genetically modified serotonin transporters assessed by structural magnetic resonance imaging (2018) (14)
Transgenic overexpression of the presynaptic choline transporter elevates acetylcholine levels and augments motor endurance (2014) (14)
Ex vivo Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant (2020) (13)
Spatial gene expression analysis of neuroanatomical differences in mouse models (2017) (13)
Physical Interactions and Functional Relationships of Neuroligin 2 and Midbrain Serotonin Transporters (2016) (13)
An interplay between the serotonin transporter (SERT) and 5-HT receptors controls stimulus-secretion coupling in sympathoadrenal chromaffin cells (2016) (13)
Tegaserod Inhibits the Serotonin Transporter SERT (2007) (12)
Choline transporter hemizygosity results in diminished basal extracellular dopamine levels in nucleus accumbens and blunts dopamine elevations following cocaine or nicotine. (2013) (12)
Sequence determinants of the Caenhorhabditis elegans dopamine transporter dictating in vivo axonal export and synaptic localization (2017) (12)
Serotonin Transporter‐Independent Actions of the Antidepressant Vortioxetine as Revealed Using the SERT M172 Mouse (2015) (11)
Effect of chronic mild stress on serotonergic markers in the skin and brain of the NC/Nga atopic-like mouse strain (2011) (11)
The State of the Serotonin Transporter Protein in the Platelets of Patients with Somatoform Disorders (2001) (11)
Glial loss of the metallo β-lactamase domain containing protein, SWIP-10, induces age- and glutamate-signaling dependent, dopamine neuron degeneration (2018) (11)
Desvenlafaxine Succinate Identifies Novel Antagonist Binding Determinants in the Human Norepinephrine Transporter (2007) (11)
Aberrant trafficking of the high‐affinity choline transporter in AP‐3‐deficient mice (2008) (11)
An automated fluorescence-based method for continuous assay of PP2A activity. (2007) (11)
Differential impact of genetically modulated choline transporter expression on the release of endogenous versus newly synthesized acetylcholine (2016) (11)
Developmental expression of the high affinity choline transporter in cholinergic sympathetic neurons (2005) (10)
Orthostatic intolerance: emerging genetic and environmental etiologies. (1999) (10)
Genetic variation in alpha2-adrenoreceptors and heart rate recovery after exercise. (2015) (10)
An open-source analytical platform for analysis of C. elegans swimming-induced paralysis (2014) (10)
Choline on the Move: Perspectives on the Molecular Physiology and Pharmacology of the Presynaptic Choline Transporter. (2016) (10)
Advances in molecular biology of neurotransmitter transporters (1992) (10)
Serotonin transporter inhibition and 5-HT2C receptor activation drive loss of cocaine-induced locomotor activation in DAT Val559 mice (2018) (10)
Y95 and E444 interaction required for high-affinity S-citalopram binding in the human serotonin transporter. (2011) (9)
Specific alterations in the levels of N-acetyl-aspartyl-glutamate in the nervous system of the dystrophic mouse (1987) (9)
Increases in testosterone levels and in copulatory behavior of male rhesus monkeys following treatment with human chorionic gonadotrophin (1980) (9)
Metallo-β-lactamase Domain-Containing Protein 1 (MBLAC1) Is a Specific, High-Affinity Target for the Glutamate Transporter Inducer Ceftriaxone. (2017) (9)
Norepinephrine and serotonin transporters: molecular insights into antidepressant targets (1993) (9)
MOLECULAR BIOLOGY OF SEROTONIN RECEPTORS AND TRANSPORTERS (1992) (9)
Inflammation-Induced Histamine Impairs the Capacity of Escitalopram to Increase Hippocampal Extracellular Serotonin (2021) (8)
Human Serotonin Transporter Coding Variation Establishes Conformational Bias with Functional Consequences. (2019) (8)
Distinctions between Dopamine Transporter Antagonists Could be Just around the Bend (2008) (8)
Acute blockade of the Caenorhabditis elegans dopamine transporter DAT-1 by the mammalian norepinephrine transporter inhibitor nisoxetine reveals the influence of genetic modifications of dopamine signaling in vivo (2016) (8)
Cell-Type-Specific Interleukin 1 Receptor 1 Signaling in the Brain Regulates Distinct Neuroimmune Activities. (2019) (8)
Serotonin rising. (2009) (7)
The SERT Met172 Mouse: An Engineered Model To Elucidate the Contributions of Serotonin Signaling to Cocaine Action. (2019) (7)
Is dopamine transporter-mediated dopaminergic signaling in the retina a noninvasive biomarker for attention-deficit/ hyperactivity disorder? A study in a novel dopamine transporter variant Val559 transgenic mouse model (2017) (7)
Adrenal serotonin derives from accumulation by the antidepressant‐sensitive serotonin transporter (2019) (6)
Molecular cloning, expression, chromosomal localization, and regulation of the human placental taurine transporter (1993) (6)
Serotonin 5-HT1B receptor-mediated behavior and binding in mice with the overactive and dysregulated serotonin transporter Ala56 variant (2021) (6)
There's no place like home? Return to the home cage triggers dopamine release in the mouse nucleus accumbens (2020) (6)
A microcomputer controlled system for monitoring multiple voltammetric electrodes in vivo (1983) (6)
Global untargeted serum metabolomic analyses nominate metabolic pathways responsive to loss of expression of the orphan metallo β-lactamase, MBLAC1. (2018) (6)
Behaviorally penetrant, anomalous dopamine efflux exposes sex and circuit dependent regulation of dopamine transporters. (2022) (5)
Neurobiology. Dopamine's reversal of fortune. (2001) (5)
A social encounter drives gene expression changes linked to neuronal function, brain development, and related disorders in mice expressing the serotonin transporter Ala56 variant (2020) (5)
Chronic desipramine treatment alters tyrosine hydroxylase but not norepinephrine transporter immunoreactivity in norepinephrine axons in the rat prefrontal cortex. (2011) (5)
Voltammetric approaches to kinetics and mechanism of the norepinephrine transporter. (1998) (5)
Molecular cloning and characterization of neurotransmitter transporters. (1992) (5)
Dopamine-dependent, swimming-induced paralysis arises as a consequence of loss of function mutations in the RUNX transcription factor RNT-1 (2019) (5)
Gene Organization and Polymorphisms of Monoamine Transporters (2002) (5)
The brain in flux: Genetic, physiologic, and therapeutic perspectives on transporters in the CNS (2014) (4)
Cholinergic neurons of mouse intrinsic cardiac ganglia contain noradrenergic enzymes, norepinephrine transporters, and the neurotrophin receptors TrkA and p75 (2009) (4)
Repetitive mild concussion in subjects with a vulnerable cholinergic system: lasting cholinergic-attentional impairments in CHT+/- mice (2019) (4)
The state of the serotonin transporter protein in the platelets of patients with somatoform [correction of somatiform] disorders. (2001) (4)
[Decrease in the platelet level of 43 kDa immunoreactive fraction of serotonin transporting protein correlates with depressive symptoms in patients with somatoform disorders]. (1999) (4)
Regulation of autism-relevant behaviors by cerebellar–prefrontal cortical circuits (2020) (3)
Head and neck cancer (HNC), depression, and genetic polymorphism (2008) (3)
Optimization of the choline transporter (CHT) inhibitor ML352: Development of VU6001221, an improved in vivo tool compound. (2016) (3)
A CONSERVED ASPARAGINE RESIDUE IN TM 1 OF THE SEROTONIN TRANSPORTER DICTATES CHLORIDE-COUPLED NEUROTRANSMITTER TRANSPORT (2011) (3)
Structural diversity in the catecholamine transporter gene family: molecular cloning and characterization of an L-epinephrine transporter from bullfrog sympathetic ganglia. (1998) (3)
The quantum dot nanoconjugate tool box (Invited Paper) (2005) (3)
Rare Opportunities for Insights Into Serotonergic Contributions to Brain and Bowel Disorders: Studies of the SERT Ala56 Mouse (2021) (3)
Synthesis and structure-activity relationships of a series of 4-methoxy-3-(piperidin-4-yl)oxy benzamides as novel inhibitors of the presynaptic choline transporter. (2015) (3)
Disrupted Choline Clearance and Sustained Acetylcholine Release In Vivo by a Common Choline Transporter Coding Variant Associated with Poor Attentional Control in Humans (2021) (3)
Faculty Opinions recommendation of Vesicular glutamate transporters 1 and 2 target to functionally distinct synaptic release sites. (2004) (3)
The brain in flux: Genetic, physiologic, and therapeutic perspectives on transporters in the CNS (2019) (3)
P.1.g.052 Serotonin transporter-independent actions of the antidepressant vortioxetine as revealed in studies of the SERT Met172 mouse (2015) (3)
Sa1676 Cholinergic Neuronal Regulation of Enteric Neurogenesis, GI Motility, and Mucosal Homeostasis: inSIGHT From Mice That Under- or Overexpress the Presynaptic Choline Transporter (2016) (2)
Hemicholinium-3 sensitive choline transport in human T lymphocytes: Evidence for use as a proxy for brain choline transporter (CHT) capacity (2017) (2)
Transgenic elimination of high-affinity antidepressant and cocaine sensitivity in the presynaptic serotonin transporter (Proceedings of the National Academy of Sciences of the United States of America (2011) 108, 9, (3785-3790) DOI: 10.1073/pnas.1011920108) (2011) (2)
New Roles for Synaptic Vesicles ? The Choline Transporter Resurfaces : (2004) (2)
Targeting the human serotonin transporter (hSERT) with quantum dots (2008) (2)
P2-086 Modeling presynaptic cholinergic hypofunction: pharmacological and behavioral studies in choline transporter heterozygous mice (2004) (1)
Imaging ligand-gated ion channels with quantum dots (2007) (1)
Dopamine Transporters: Chemistry, Biology, and Pharmacology.Wiley Series in Drug Discovery and Development.Edited byMark L. Trudell and Sari Izenwasser. Hoboken (New Jersey): John Wiley & Sons. $110.00. xii + 443 p. + 8 pl.; ill. index. ISBN: 978‐0‐470‐11790‐3. 2008. (2010) (1)
Serotonin-releasing agents with reduced off-target effects (2022) (1)
Contents Vol. 18, 1996 (2004) (1)
Effect of chronic mild stress on skin and brain in the NC/Nga atopic-like mouse (2011) (1)
Male DAT Val559 Mice Exhibit Compulsive Behavior under Devalued Reward Conditions Accompanied by Cellular and Pharmacological Changes (2022) (1)
1 SEROTONIN AND COCAINE-SENSITIVE INACTIVATION OF HUMAN SEROTONIN TRANSPORTERS BY METHANETHIOSULFONATES TARGETED TO TRANSMEMBRANE DOMAIN 1 (2003) (1)
Synthesis and Evaluation of PET Radiotracers for the Presynaptic High-affinity Choline Transporter (2016) (1)
Platelet serotonin transporter protein polymorphism in patients with somatoform affective disorders (1999) (1)
Adverse Remodeling and Pump Failure in Hearts With Pressure Overload Mediated Enhanced Catabolism of Norepinephrine Contributes to − Monoamine Oxidase (2009) (1)
Gene Organization and Polymorphisms of Monoamine Transporters Relationship to Psychiatric and Other Complex Diseases (2013) (1)
[The status of serotonin protein -- a serotonin transporter in thrombocytes in patients with somatoform disorders]. (1999) (1)
Regulation of the dopamine transporter by dopamine D2 receptors and the AKT‐GSK3 signaling cascade (2011) (1)
Sex and Circuit Specific Dopamine Transporter Regulation Underlies Unique Behavioral Trajectories of Functional SLC6A3 Coding Variation (2021) (1)
RECENT PROGRESS IN TRANSPORTER RESEARCH (1997) (0)
Serotonin in the orbitofrontal cortex enhances cognitive flexibility (2023) (0)
Identification of residues in the serotonin transporter engaged in high affinity recognition of antidepressants and cocaine (2006) (0)
Contents Vol. 27, 2005 (2005) (0)
Genetic Risk Factors For Long-Term Cognitive Impairment After Critical Illness (2010) (0)
Is dopamine transporter-mediated dopaminergic signaling in the retina a noninvasive biomarker for attention-deficit/ hyperactivity disorder? A study in a novel dopamine transporter variant Val559 transgenic mouse model (2017) (0)
A Novel Approach to Cholinergic Signaling Modulation: Development and Characterization of ML352, a Novel, Noncompetitive Inhibitor of the Presynaptic Choline Transporter (2015) (0)
Correction: Sakrikar et al., Attention Deficit/Hyperactivity Disorder-Derived Coding Variation in the Dopamine Transporter Disrupts Microdomain Targeting and Trafficking Regulation (2012) (0)
Subject Index Vol. 27, 2005 (2005) (0)
Distribution and function of neuronal IL-1R1 in the CNS (2022) (0)
The SLC6 transporters: perspectives on structure, functions, regulation, and models for transporter dysfunction (2013) (0)
Subject Index Vol. 18, 1996 (1996) (0)
Acknowledgement to Reviewers (1994) (0)
180 Analysis of a Hyperfunctional Autism-Associated Variant, Knockout, and Inhibition of the Serotonin Reuptake Transporter (SERT) in Mice Reveals That Enteric Nervous System Development, Gastrointestinal Motility, and Mucosal Homeostasis Are Highly Dependent on 5-HT, SERT, and 5-HT4 Receptors (2016) (0)
A critical site in the human serotonin transporter defines Na+ and Cl‐ dependence (2006) (0)
Conditional Knockout of the Serotonin Transporter (SERT) Demonstrates Its Role in Accumulating and Maintaining 5-HT Homeostasis in the Sympathoadrenal System (2019) (0)
Acknowledgment to reviewers (1996) (0)
Beyond Prozac: Generation and characterization of SSRI Insensitive Transgenic Mice (2009) (0)
Reviewer list for 2005 (2005) (0)
P4-144 The high-affinity choline transporter (CHT) functional variant 189V in Alzheimer's disease: an association study (2004) (0)
Serotonin transporter-mediated regulation of adrenal chromaffin cells (2014) (0)
Sequence variation in the human dopamine transporter gene in subjects with bipolar disorder (2009) (0)
Voltammetric Studies on the Kinetics and Mechanism of Catecholamine Transporters (1996) (0)
Terminalsat Vesamicol-Treated Motor Nerve Empty Synaptic Vesicles Recycle and Undergo (2015) (0)
Dipeptides containing glutamate as endogenous neuroexcitatory agents (1986) (0)
Acknowledgement to reviewers (2004) (0)
Impact of dopamine transporter-mediated, non-vesicular DA release on ADHD traits as studied in the DAT Val559 mouse model (2016) (0)
a Model Of Cognitive Dysfunction: Constrained Demands On Cholinergic Transmission And Attentional Capacities In Cht + /− Mice : Op03-06 (2009) (0)
Methylene Dioxymethamphetamine Serotonin and the Psychostimulant Aqueously Accessible Binding Pocket for Serotonin Transporter Contributes to an Transmembrane Domain 6 of the Human Protein Structure and Folding : (2010) (0)
Interrogating endogenous neuromodulatory GPCR signal processing by real‐time imaging of cAMP dynamics through intact neuronal circuits (2018) (0)
Serotonin Transporter Ala276 Mouse: Novel Model to Assess the Neurochemical and Behavioral Impact of Thr276 Phosphorylation In Vivo (2021) (0)
Chronic Antagonism of p38α MAPK Normalizes Serotonin Clearance, Serotonin Receptor Hypersensitivity and Social Behavior Deficits in a Genetic Murine Model of Autism Spectrum Disorder (2016) (0)
Allosteric Modulator KM822 Attenuates Behavioral Actions of Amphetamine in C. elegans through Interactions with the Dopamine Transporter DAT-1 (2021) (0)
Do neuroinflammatory pathways contribute to serotoninergic alterations in autism? p38alpha MAPK signaling drives perturbed serotonin clearance, receptor hypersensitivity, and social behavior deficits in the SERT Ala56 mouse (2017) (0)
Abstract # 2043 Contributions of inflammatory cytokine signaling to the enduring effects of early-life stress: A serotonin connection? (2019) (0)
Do CHT Inhibitors Constitute a Possible Therapeutic Strategy for Dystonia? Studies with the Novel CHT Inhibitor ML352 (2016) (0)
Acknowledgement of Reviewers (2001) (0)
Acknowledgement to Reviewers (2005) (0)
The Role of the Dopamine Transporter in Attention Deficit Hyperactivity Disorder (2009) (0)
A device to rapidly core out tissue culture plates for autoradiographic visualization of cells transfected with cDNA libraries. (1990) (0)
Allosteric Modulator KM822 Attenuates Behavioral Actions of Amphetamine in Caenorhabditis elegans through Interactions with the Dopamine Transporter DAT-1 (2021) (0)
Serotonin confessions of a dirty drug: dissecting the role of the serotonin transporter in cocaine action using SERT I172M mice (848.5) (2014) (0)
Thought You Knew Them Biogenic Amine Neurotransmitter Transporters : Just When You (2005) (0)
Molecular Dopamine Transporter Efflux in ADHD (2008) (0)
Pharmacologic Inhibition and Genetic Elimination of p38α MAPK Normalizes Serotonergic System Alterations and Social Behavior Deficits in the SERT Ala56 Mouse Model of Autism Spectrum Disorder (2017) (0)
Antidepressant-Sensitive Norepinephrine Transporters: Structure and Regulation (2004) (0)
Kappa Opioid Receptor Antagonism Rescues Genetic Perturbation of Dopamine Homeostasis: Molecular, Physiological and Behavioral Consequences (2023) (0)
A Genetic Deficiency in Presynaptic Choline Uptake Leads to Resting Tachycardia and Diminished Vagal Reserve (2008) (0)
Serotonin-Labeled CdSe Nanocrystals: Applications for Neuroscience (2000) (0)
2013 Daniel H. Efron Research Award (2012) (0)
TITLE PAGE DESVENLAFAXINE SUCCINATE ( DVS ) IDENTIFIES NOVEL ANTAGONIST BINDING DETERMINANTS IN THE HUMAN NOREPINEPHRINE TRANSPORTER (2007) (0)
Acknowledgment of Reviewers (1996) (0)
Serotonin and Supermodels: Model‐guided exploration of hSERT TM6 (2008) (0)
JPET # 125716 1 DESVENLAFAXINE SUCCINATE ( DVS ) IDENTIFIES NOVEL ANTAGONIST BINDING DETERMINANTS IN THE HUMAN NOREPINEPHRINE TRANSPORTER (2007) (0)
IL-1 receptor signaling in podocytes limits susceptibility to glomerular damage. (2021) (0)
Serotonin and Autism Spectrum Disorder: Clues to a 50 Year Old Mystery (2014) (0)
27 Effects of Gain-of-Function Mutation in the Serotonin Transporter (SERT) in Mice Suggest That 5-HT Functions in Intestinal Motility, Mucosal Maintenance, Inflammation, and Prevention of Bacterial Overgrowth and Translocation (2014) (0)
Does Presynaptic GSK‐3Beta Signaling Play a Role in Bipolar Disorder: Studies of on Dopamine Transporter (DAT) Coding Variants (2010) (0)
TITLE:"SEROTONERGIC MODULATION OF SUPRAGRANULAR NEURONS IN RAT NEOCORTEX" (2002) (0)
VigorousMotorActivityinCaenorhabditiselegansRequires EfficientClearanceofDopamineMediatedbySynaptic LocalizationoftheDopamineTransporterDAT-1 (2007) (0)
ADHD-Derived Coding Variation in the Dopamine Transporter Disrupts Microdomain Targeting and Trafficking Regulation (2012) (0)
Acknowledgements to Reviewers (2004) (0)
Molecular Genetics of Childhood and Adolescent Onset Psychiatric Disorders (2011) (0)
Single Molecule Analysis of Serotonin Transporter Regulation Using Quantum Dots (2011) (0)
Molecular cloning and characterization of hemicholinium-3-sensitive choline transporters (2001) (0)
Positions available (1995) (0)
Searching for Novel Genetic Variation in Neurotransmitter Transporters (2003) (0)
P.1.g.065 A study of chronic vortioxetine in the SERT Met172 mouse suggests antidepressant-like properties that do not require serotonin transporter inhibition (2016) (0)
Title: Sex and Circuit Specific Dopamine Transporter Regulation Underlies Unique Behavioral Trajectories of Functional SLC6A3 Coding Variation Running Title (50 Characters): Sexual dimorphism in DAT Val559 mice Authors/Affiliations (2021) (0)
associated with autism Enhanced activity of human serotonin transporter variants (2008) (0)
Controlling Stimulus-Secretion Coupling in Adrenal Chromaffin Cells: A Novel Role for the Serotonin Transporter? (2015) (0)
Functional Disturbances in DA Homeostasis and Signaling Revealed Through the Study of Rare Dopamine Transporter Coding Variants (2014) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Randy D. Blakely?

Randy D. Blakely is affiliated with the following schools:

Randy D. Blakely's Academic­Influence.com Rankings